Role of KIRs and KIR ligands in hematopoietic transplantation

Rosen, 2008, Up on the tightrope: natural killer cell activation and inhibition, Nat Immunol, 9, 495, 10.1038/ni1581 Gasser, 2006, Activation and self-tolerance of natural killer cells, Immunol Rev, 214, 130, 10.1111/j.1600-065X.2006.00460.x Yokoyama, 2006, Licensing of natural killer cells by self-major histocompatibility complex class I, Immunol Rev, 214, 143, 10.1111/j.1600-065X.2006.00458.x Parham, 2006, Taking license with natural killer cell maturation and repertoire development, Immunol Rev, 214, 155, 10.1111/j.1600-065X.2006.00462.x Thananchai, 2007, Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B, J Immunol, 178, 33, 10.4049/jimmunol.178.1.33 Foley, 2008, The reactivity of Bw4-positive HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplants, Blood, 112, 435, 10.1182/blood-2008-01-132902 Stern, 2008, Human leukocyte antigens A23, A24 and A32 but not A25 are ligands for KIR3DL1, Blood, 112, 708, 10.1182/blood-2008-02-137521 Fernandez, 2005, A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules, Blood, 105, 4416, 10.1182/blood-2004-08-3156 Kim, 2005, Licensing of natural killer cells by host major histocompatibility complex class I molecules, Nature, 436, 709, 10.1038/nature03847 Anfossi, 2006, Human NK cell education by inhibitory receptors for MHC class I, Immunity, 2, 331, 10.1016/j.immuni.2006.06.013 Moretta, 2004, Killer immunoglobulin-like receptors, Curr Opin Immunol, 16, 626, 10.1016/j.coi.2004.07.010 Ciccone, 1992, Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans, J Exp Med, 175, 709, 10.1084/jem.175.3.709 Colonna, 1993, Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C, Science, 260, 1121, 10.1126/science.8493555 Valiante, 1997, Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors, Immunity, 7, 739, 10.1016/S1074-7613(00)80393-3 Farag, 2002, Natural Killer cell receptors: new biology and insights into the graft versus leukemia effect, Blood, 100, 1935, 10.1182/blood-2002-02-0350 Velardi, 2002, NK-cells: a lesson from mismatched haematopoietic transplantation, Trends Immunol, 23, 438, 10.1016/S1471-4906(02)02284-6 Parham, 2003, Alloreactive killer cells: hindrance and help for haematopoietic transplants, Nat Rev Immunol, 3, 108, 10.1038/nri999 Ruggeri, 2006, Haploidentical transplantation and natural killer cell recognition of missing self, Immunol Rev, 214, 202, 10.1111/j.1600-065X.2006.00455.x Uhrberg, 1997, Human diversity in killer-cell inhibitory receptor genes, Immunity, 7, 753, 10.1016/S1074-7613(00)80394-5 Ruggeri, 1999, Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation, Blood, 94, 333, 10.1182/blood.V94.1.333.413a31_333_339 Ruggeri, 2002, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science, 295, 2097, 10.1126/science.1068440 Kärre, 2002, A perfect mismatch, Science, 295, 2029, 10.1126/science.1070538 Ruggeri, 2007, Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value, Blood, 110, 433, 10.1182/blood-2006-07-038687 Hsu, 2002, The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism, Immunol Rev, 190, 40, 10.1034/j.1600-065X.2002.19004.x Pando, 2003, The protein made from a common allele of KIR3DL1 (3DL*004) is poorly expressed at cell surfaces due to substitution at position 86 in Ig domain 0 and 182 in Ig domain 1, J Immunol, 171, 6640, 10.4049/jimmunol.171.12.6640 Thomas, 2008, Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?, J Immunol, 180, 6743, 10.4049/jimmunol.180.10.6743 Igarashi, 2004, Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells, Blood, 104, 170, 10.1182/blood-2003-12-4438 Stern M, Ruggeri L, Mancusi A, Bernardo ME, De Angelis C, Bucher C, Locatelli F, Aversa F, Velardi A: Survival after T-cell depleted haploidentical stem cell transplantation is improved with mothers as donors. Blood 2008, in press (Epub ahead of print May 20, 2008). Hansasuta, 2004, Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific, Eur J Immunol, 34, 1673, 10.1002/eji.200425089 Cooley, 2005, KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation, Blood, 106, 4370, 10.1182/blood-2005-04-1644 Davies, 2002, Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants, Blood, 100, 3825, 10.1182/blood-2002-04-1197 Lowe, 2003, T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation, Br J Haematol, 123, 323, 10.1046/j.1365-2141.2003.04604.x Bornhauser, 2004, Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors, Blood, 103, 2860, 10.1182/blood-2003-11-3893 Farag, 2006, The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry, Biol Blood Marrow Transplant, 12, 876, 10.1016/j.bbmt.2006.05.007 Hsu, 2006, KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy, Biol Blood Marrow Transpl, 12, 828, 10.1016/j.bbmt.2006.04.008 Kröger, 2006, Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation, Transplantation, 82, 1024, 10.1097/01.tp.0000235859.24513.43 Yabe, 2008, Donor killer immunoglobulin-like receptor (KIR) genotype–patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C–KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation, Biol Blood Marrow Transplant, 14, 75, 10.1016/j.bbmt.2007.09.012 Giebel, 2003, Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors, Blood, 102, 814, 10.1182/blood-2003-01-0091 Beelen, 2005, Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias, Blood, 105, 2594, 10.1182/blood-2004-04-1441 Elmaagacli, 2005, Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor, Transplantation, 79, 1741, 10.1097/01.TP.0000164500.16052.3C Kröger, 2005, Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma, Br J Haematol, 129, 631, 10.1111/j.1365-2141.2005.05513.x Dawson, 2005, Successful use of haploidentical stem-cell transplantation with KIR mismatch as initial therapy for poor-risk myelodysplastic syndrome, J Clin Oncol, 23, 4473, 10.1200/JCO.2005.01.3581 Leung, 2004, Determinants of antileukemia effects of allogeneic NK cells, J Immunol, 172, 644, 10.4049/jimmunol.172.1.644 Leung, 2005, Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors, J Immunol, 174, 6540, 10.4049/jimmunol.174.10.6540 Dupont, 2004, Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in hematopoietic stem cell transplantation, Curr Opin Immunol, 16, 623, 10.1016/j.coi.2004.07.013 Hsu, 2005, Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes, Blood, 105, 4878, 10.1182/blood-2004-12-4825 Hsu, 2007, Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component, Tissue Antigens, 69, 42, 10.1111/j.1399-0039.2006.759_5.x Miller, 2007, Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT, Blood, 109, 5058, 10.1182/blood-2007-01-065383 Parham, 2005, MHC class I molecules and KIRs in human history, health and survival, Nat Rev Immunol, 5, 201, 10.1038/nri1570 Verheyden, 2005, A defined donor activating natural killer cell receptor genotype protects against leukaemic relapse after related HLA-identical hematopoietic stem cell transplantation, Leukemia, 19, 1446, 10.1038/sj.leu.2403839 De Santis, 2005, Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants, Tissue Antigens, 65, 519, 10.1111/j.1399-0039.2005.00396.x Cook, 2006, Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation, Blood, 107, 1230, 10.1182/blood-2005-03-1039 Chen, 2006, Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders, Bone Marrow Transplant, 38, 437, 10.1038/sj.bmt.1705468 Cook, 2004, The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling haematopoietic stem cell transplantation for myeloid leukemia, Blood, 103, 1521, 10.1182/blood-2003-02-0438 Bishara, 2004, The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD, Tissue Antigens, 63, 204, 10.1111/j.0001-2815.2004.00182.x Sun, 2005, Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML, Bone Marrow Transplant, 36, 525, 10.1038/sj.bmt.1705089 McQueen, 2007, Donor–recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation, Hum Immunol, 68, 309, 10.1016/j.humimm.2007.01.019